Skip to main content

. 1980 May;41(5):841–842. doi: 10.1038/bjc.1980.153

In vitro activity of daunomycin-anti-alphafoetoprotein conjugate on mouse hepatoma cells.

M Belles-Isles, M Pagé

PMCID: PMC2010303 PMID: 6158968

841

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

GOLD P., FREEDMAN S. O. DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES. J Exp Med. 1965 Mar 1;121:439–462. doi: 10.1084/jem.121.3.439. [DOI] [PMC free article] [PubMed] [Google Scholar]
Gregoriadis G. Targeting of drugs. Nature. 1977 Feb 3;265(5593):407–411. doi: 10.1038/265407a0. [DOI] [PubMed] [Google Scholar]
Hurwitz E., Levy R., Maron R., Wilchek M., Arnon R., Sela M. The covalent binding of daunomycin and adriamycin to antibodies, with retention of both drug and antibody activities. Cancer Res. 1975 May;35(5):1175–1181. [PubMed] [Google Scholar]
Rubens R. D. Antibodies as carriers of anticancer agents. Lancet. 1974 Mar 23;1(7856):498–499. doi: 10.1016/s0140-6736(74)92799-8. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES